US Patent Issued to IL-2RX on July 7 for "Compounds, compositions, methods, and uses for treating cancer and immunological disorders" (California Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,109, issued on July 7, was assigned to IL-2RX (San Jose, Calif.).

"Compounds, compositions, methods, and uses for treating cancer and immunological disorders" was invented by Luis R.B. Soares (San Jose, Calif.) and Clarence Ray Hurt (San Jose, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides novel polypeptide-therapeutic compound or hormone-therapeutic compound conjugates using cleavable or non-cleavable linkers, whereby the polypeptide or hormone serves to target specific cells using receptor expression on the targeted cell to bind the ligand (polypeptide or hormone) carrying the therapeutic compound unlike antib...